Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...
NANOLEK announced the launch of industrial production of CoviVac. Investments in this project amounted to 40 million rubles, the company said. The manufacturer plans...
Investments in the vaccine production are over 2 billion rubles.
The production capacity is about 4 million vaccine doses per month.
When the domestic market is...
The American Journal of Translational Research has published successful results of the Phase 3 clinical trial of Coronavir (INN: favipiravir). This study aimed to evaluate the efficacy and safety of favipiravir for treatment of mild...
The first three batches, more than 11,000 packs, of the drug Deltyba are ready for shipment to Russian healthcare facilities. The medicine for treatment of drug-resistant tuberculosis, manufactured...
In his speech at the «360 degree Pharmaceutical Supply» conference, Maxim Smagin, General Director of Promomed Group said:
The domestic health care system has...